{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:05:31Z","timestamp":1790885131438,"version":"4.1.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/j.coph.2008.12.001","type":"journal-article","created":{"date-parts":[[2009,1,21]],"date-time":"2009-01-21T15:32:02Z","timestamp":1232551922000},"page":"46-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":117,"title":["Endocannabinoid signals in the control of emotion"],"prefix":"10.1016","volume":"9","author":[{"given":"Beat","family":"Lutz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2008.12.001_bib1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1146\/annurev.neuro.23.1.155","article-title":"Emotion circuits in the brain","volume":"23","author":"LeDoux","year":"2000","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.coph.2008.12.001_bib2","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/YCO.0b013e3280115e52","article-title":"Combined pharmacotherapy and cognitive-behavioural therapy for anxiety disorders","volume":"20","author":"Pull","year":"2007","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/j.coph.2008.12.001_bib3","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrn1247","article-title":"The molecular logic of endocannabinoid signalling","volume":"4","author":"Piomelli","year":"2003","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.coph.2008.12.001_bib4","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/pr.58.3.2","article-title":"The endocannabinoid system as an emerging target of pharmacotherapy","volume":"58","author":"Pacher","year":"2006","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.coph.2008.12.001_bib5_1","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1021\/cr0782067","article-title":"Enzymatic pathways that regulate endocannabinoid signaling in the nervous system","volume":"108","author":"Ahn","year":"2008","journal-title":"Chem Rev"},{"key":"10.1016\/j.coph.2008.12.001_bib6","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/sj.bjp.0707423","article-title":"Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors","volume":"152","author":"O'Sullivan","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.coph.2008.12.001_bib7","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/sj.npp.1301118","article-title":"N-arachidonoyl-dopamine tunes synaptic transmission onto dopaminergic neurons by activating both cannabinoid and vanilloid receptors","volume":"32","author":"Marinelli","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.coph.2008.12.001_bib8","doi-asserted-by":"crossref","first-page":"21054","DOI":"10.1074\/jbc.M708908200","article-title":"Identification of farnesyl pyrophosphate and N-arachidonylglycine as endogenous ligands for GPR92","volume":"283","author":"Oh","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coph.2008.12.001_bib9_1","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/nn2042","article-title":"Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum","volume":"11","author":"Maccarrone","year":"2008","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.coph.2008.12.001_bib10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.pharmthera.2007.01.005","article-title":"Biochemistry and pharmacology of endovanilloids","volume":"114","author":"Starowicz","year":"2007","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.coph.2008.12.001_bib11","doi-asserted-by":"crossref","first-page":"52908","DOI":"10.1155\/2007\/52908","article-title":"Endocannabinoid system and synaptic plasticity: implications for emotional responses","volume":"2007","author":"Viveros","year":"2007","journal-title":"Neural Plast"},{"key":"10.1016\/j.coph.2008.12.001_bib12_1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.phrs.2007.09.006","article-title":"The endocannabinoid system in the processing of anxiety and fear and how CB1 receptors may modulate fear extinction","volume":"56","author":"Lafenetre","year":"2007","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.coph.2008.12.001_bib13_1","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1111\/j.1460-9568.2008.06266.x","article-title":"Adaptations in endocannabinoid signaling in response to repeated homotypic stress: a novel mechanism for stress habituation","volume":"27","author":"Patel","year":"2008","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.coph.2008.12.001_bib14","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0079-6123(08)00433-0","article-title":"Role of the endocannabinoid system in regulation of the hypothalamic\u2013pituitary\u2013adrenocortical axis","volume":"170","author":"Steiner","year":"2008","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.coph.2008.12.001_bib15","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1517\/14728222.12.11.1347","article-title":"The cannabinoid CB1 receptor and the endocannabinoid anandamide: possible antidepressant targets","volume":"12","author":"Bambico","year":"2008","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.coph.2008.12.001_bib16","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s12035-007-8004-x","article-title":"The endocannabinoid system and extinction learning","volume":"36","author":"Lutz","year":"2007","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.coph.2008.12.001_bib17","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1369-1600.2008.00104.x","article-title":"The endocannabinoid system: emotion, learning and addiction","volume":"13","author":"Moreira","year":"2008","journal-title":"Addict Biol"},{"key":"10.1016\/j.coph.2008.12.001_bib18","doi-asserted-by":"crossref","unstructured":"Moreira FA, Grieb M, Lutz B: Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression. Best Pract Res Clin Endocrinol & Metabol 2009, in press.","DOI":"10.1016\/j.beem.2008.09.003"},{"key":"10.1016\/j.coph.2008.12.001_bib19_1","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1088208","article-title":"CB1 cannabinoid receptors and on-demand defense against excitotoxicity","volume":"302","author":"Marsicano","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.coph.2008.12.001_bib20","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.bcp.2004.07.007","article-title":"On-demand activation of the endocannabinoid system in the control of neuronal excitability and epileptiform seizures","volume":"68","author":"Lutz","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.coph.2008.12.001_bib21","doi-asserted-by":"crossref","first-page":"e269","DOI":"10.1371\/journal.pbio.0050269","article-title":"Genetic dissection of behavioural and autonomic effects of Delta(9)-tetrahydrocannabinol in mice","volume":"5","author":"Monory","year":"2007","journal-title":"PLoS Biol"},{"key":"10.1016\/j.coph.2008.12.001_bib22","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neuropharm.2007.07.005","article-title":"Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors","volume":"54","author":"Moreira","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.coph.2008.12.001_bib23","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00213-008-1209-5","article-title":"An endocannabinoid signaling system modulates anxiety-like behavior in male Syrian hamsters","volume":"200","author":"Moise","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.coph.2008.12.001_bib24","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/npp.2008.98","article-title":"Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels","volume":"34","author":"Micale","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.coph.2008.12.001_bib25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.neuropharm.2007.06.024","article-title":"CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour","volume":"54","author":"Rubino","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.coph.2008.12.001_bib26_1","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/cercor\/bhm161","article-title":"Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex","volume":"18","author":"Rubino","year":"2008","journal-title":"Cereb.Cortex"},{"key":"10.1016\/j.coph.2008.12.001_bib27","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neuropharm.2007.08.011","article-title":"The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition","volume":"54","author":"Scherma","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.coph.2008.12.001_bib28_1","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1523\/JNEUROSCI.3303-06.2007","article-title":"Reduced anxiety, conditioned fear, and hippocampal long-term potentiation in transient receptor potential vanilloid type 1 receptor-deficient mice","volume":"27","author":"Marsch","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.coph.2008.12.001_bib29","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/FBP.0b013e3283123c83","article-title":"Cannabinoid CB1 receptors of the rat central amygdala mediate anxiety-like behavior: interaction with the opioid system","volume":"19","author":"Zarrindast","year":"2008","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.coph.2008.12.001_bib30","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ejphar.2006.10.038","article-title":"5-HT1A receptors are involved in the anxiolytic effect of Delta9-tetrahydrocannabinol and AM 404, the anandamide transport inhibitor, in Sprague\u2013Dawley rats","volume":"555","author":"Braida","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.coph.2008.12.001_bib31_1","doi-asserted-by":"crossref","first-page":"6677","DOI":"10.1523\/JNEUROSCI.0153-06.2006","article-title":"Cannabinoid CB1 receptor mediates fear extinction via habituation-like processes","volume":"26","author":"Kamprath","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.coph.2008.12.001_bib32","doi-asserted-by":"crossref","unstructured":"Kamprath K, Plendl W, Marsicano G, Deussing JM, Wurst W, Lutz B, Wotjak CT: Endocannabinoids mediate acute fear adaptation via glutamatergic neurons independently of CRH signaling. Genes Brain Behav 2008, in press, doi:10.1111\/j.1601-183X.2008.00463.x.","DOI":"10.1111\/j.1601-183X.2008.00463.x"},{"key":"10.1016\/j.coph.2008.12.001_bib33","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejphar.2005.01.008","article-title":"Cannabinoid CB1 receptor is dispensable for memory extinction in an appetitively-motivated learning task","volume":"510","author":"H\u00f6lter","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.coph.2008.12.001_bib34","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1101\/lm.1113008","article-title":"Differential endocannabinoid regulation of extinction in appetitive and aversive Barnes maze tasks","volume":"15","author":"Harloe","year":"2008","journal-title":"Learn Mem"},{"key":"10.1016\/j.coph.2008.12.001_bib35","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1101\/lm.888808","article-title":"Activation of LVGCCs and CB1 receptors required for destabilization of reactivated contextual fear memories","volume":"15","author":"Suzuki","year":"2008","journal-title":"Learn Mem"},{"key":"10.1016\/j.coph.2008.12.001_bib36","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00213-008-1156-1","article-title":"Activation of CB1 cannabinoid receptors in the dorsolateral periaqueductal gray reduces the expression of contextual fear conditioning in rats","volume":"198","author":"Resstel","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.coph.2008.12.001_bib37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejphar.2008.07.032","article-title":"Activation of cannabinoid CB1 receptors in the dorsolateral periaqueductal gray induces anxiolytic effects in rats submitted to the Vogel conflict test","volume":"593","author":"Lisboa","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.coph.2008.12.001_bib38","doi-asserted-by":"crossref","first-page":"6643","DOI":"10.1523\/JNEUROSCI.5126-05.2006","article-title":"Opposing crosstalk between leptin and glucocorticoids rapidly modulates synaptic excitation via endocannabinoid release","volume":"26","author":"Malcher-Lopes","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.coph.2008.12.001_bib39","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.psyneuen.2008.06.004","article-title":"Conditional cannabinoid receptor type 1 mutants reveal neuron subpopulation-specific effects on behavioral and neuroendocrine stress responses","volume":"33","author":"Steiner","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.coph.2008.12.001_bib40","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/1073858406296407","article-title":"The endocannabinoid system and neurogenesis in health and disease","volume":"13","author":"Galve-Roperh","year":"2007","journal-title":"Neuroscientist"},{"key":"10.1016\/j.coph.2008.12.001_bib41","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/978-3-540-74805-2_14","article-title":"Presynaptic modulation by endocannabinoids","author":"Lovinger","year":"2008","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.coph.2008.12.001_bib42_1","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.neuron.2007.12.027","article-title":"TRPV1 channels mediate long-term depression at synapses on hippocampal interneurons","volume":"57","author":"Gibson","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.coph.2008.12.001_bib43","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.neuron.2006.07.006","article-title":"The endocannabinoid system controls key epileptogenic circuits in the hippocampus","volume":"51","author":"Monory","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.coph.2008.12.001_bib44","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/nm.f.1869","article-title":"Endocannabinoid signaling as a synaptic circuit breaker in neurological disease","volume":"14","author":"Katona","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.coph.2008.12.001_bib45","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nature00839","article-title":"The endogenous cannabinoid system controls extinction of aversive memories","volume":"418","author":"Marsicano","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.coph.2008.12.001_bib46","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1460-9568.2005.03916.x","article-title":"Inhibition of restraint stress-induced neural and behavioural activation by endogenous cannabinoid signalling","volume":"21","author":"Patel","year":"2005","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.coph.2008.12.001_bib47","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1111\/j.1471-4159.2008.05567.x","article-title":"Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment","volume":"106","author":"Hill","year":"2008","journal-title":"J Neurochem"},{"issue":"Suppl. 1","key":"10.1016\/j.coph.2008.12.001_bib48","doi-asserted-by":"crossref","first-page":"i16","DOI":"10.1093\/cercor\/bhm103","article-title":"Cannabinoid-mediated disinhibition and working memory: dynamical interplay of multiple feedback mechanisms in a continuous attractor model of prefrontal cortex","volume":"17","author":"Carter","year":"2007","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.coph.2008.12.001_bib49","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00213-007-1055-x","article-title":"Endocannabinoids modulate encoding of sequential memory in the rat hippocampus","volume":"198","author":"Deadwyler","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.coph.2008.12.001_bib50","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1111\/j.1460-9568.2006.04697.x","article-title":"Variations in the human cannabinoid receptor (CNR1) gene modulate striatal responses to happy faces","volume":"23","author":"Chakrabarti","year":"2006","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.coph.2008.12.001_bib51","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.euroneuro.2008.05.003","article-title":"Cannabinoid receptor 1 (CNR1) gene: impact on antidepressant treatment response and emotion processing in major depression","volume":"18","author":"Domschke","year":"2008","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.coph.2008.12.001_bib52","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/ajmg.b.30693","article-title":"Association of the cannabinoid receptor gene (CNR1) with ADHD and post-traumatic stress disorder","volume":"147B","author":"Lu","year":"2008","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.coph.2008.12.001_bib53","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/sj.npp.1300496","article-title":"The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis","volume":"29","author":"D'Souza","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.coph.2008.12.001_bib54","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1523\/JNEUROSCI.5603-07.2008","article-title":"Cannabinoid modulation of amygdala reactivity to social signals of threat in humans","volume":"28","author":"Phan","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.coph.2008.12.001_bib55","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1001\/jama.299.13.1547","article-title":"Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial","volume":"299","author":"Nissen","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.coph.2008.12.001_bib56","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1177\/0091270008317591","article-title":"Multiple-dose pharmacokinetics, pharmacodynamics, and safety of taranabant, a novel selective cannabinoid-1 receptor inverse agonist, in healthy male volunteers","volume":"48","author":"Addy","year":"2008","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.coph.2008.12.001_bib57","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.cmet.2007.11.012","article-title":"The acyclic CB1R inverse agonist taranabant mediates weight loss by increasing energy expenditure and decreasing caloric intake","volume":"7","author":"Addy","year":"2008","journal-title":"Cell Metab"},{"key":"10.1016\/j.coph.2008.12.001_bib58","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.conb.2008.08.007","article-title":"Wiring and firing neuronal networks: endocannabinoids take center stage","volume":"18","author":"Harkany","year":"2008","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.coph.2008.12.001_bib59","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1126\/science.1137406","article-title":"Hardwiring the brain: endocannabinoids shape neuronal connectivity","volume":"316","author":"Berghuis","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.coph.2008.12.001_bib60_1","doi-asserted-by":"crossref","first-page":"8760","DOI":"10.1073\/pnas.0803545105","article-title":"Endocannabinoid signaling controls pyramidal cell specification and long-range axon patterning","volume":"105","author":"Mulder","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coph.2008.12.001_bib61","doi-asserted-by":"crossref","first-page":"23892","DOI":"10.1074\/jbc.M700678200","article-title":"The CB1 cannabinoid receptor mediates excitotoxicity-induced neural progenitor proliferation and neurogenesis","volume":"282","author":"Aguado","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coph.2008.12.001_bib62_1","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1369-1600.2008.00110.x","article-title":"Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure","volume":"13","author":"Schneider","year":"2008","journal-title":"Addict Biol"},{"key":"10.1016\/j.coph.2008.12.001_bib63","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.neubiorev.2005.04.005","article-title":"Maternal smoking, drinking or cannabis use during pregnancy and neurobehavioral and cognitive functioning in human offspring","volume":"30","author":"Huizink","year":"2006","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.coph.2008.12.001_bib64","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/YCO.0b013e3280fa838e","article-title":"Cannabis use and psychiatric and cognitive disorders: the chicken or the egg?","volume":"20","author":"Di Forti","year":"2007","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/j.coph.2008.12.001_bib65","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nchembio.129","article-title":"Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects","volume":"5","author":"Long","year":"2009","journal-title":"Nat Chem Biol"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489208002014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489208002014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T06:47:40Z","timestamp":1761461260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489208002014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S1471489208002014"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2008.12.001","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endocannabinoid signals in the control of emotion","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2008.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}